Get started
Author

Maria Angeles Ceregido

Observed names: Ceregido, Maria Angeles, M. Angeles Ceregido, Maria Angeles Ceregido
ORCID: 0009-0004-5412-2641
Observed ORCID: 0009-0004-5412-2641
OpenAlex ID: A5065468516
A systematic review of the burden of pertussis disease in infants and the effectiveness of maternal immunization against pertussis
2020 · Walid Kandeil, Caroline van den Ende, et al. · Expert Review of Vaccines · 133
PDF
Adjuvant system AS01: from mode of action to effective vaccines
2024 · François Roman, Wivine Burny, et al. · Expert Review of Vaccines · 98
Safety and immunogenicity of a SARS-CoV-2 recombinant protein nanoparticle vaccine (GBP510) adjuvanted with AS03: A randomised, placebo-controlled, observer-blinded phase 1/2 trial
2022 · Joon Young Song, Won Suk Choi, et al. · EClinicalMedicine · 96
PDF
Safety and immunogenicity of an AS03-adjuvanted plant-based SARS-CoV-2 vaccine in Adults with and without Comorbidities
2022 · Nathalie Charland, Philipe Gobeil, et al. · npj Vaccines · 39
PDF
Immunogenicity, transplacental transfer of pertussis antibodies and safety following pertussis immunization during pregnancy: Evidence from a randomized, placebo-controlled trial
2019 · Kirsten P. Perrett, Scott A. Halperin, et al. · Vaccine · 39
Phase 2 Randomized Trial of an AS03 Adjuvanted Plant-Based Virus-Like Particle Vaccine for Covid-19 in Healthy Adults, Older Adults and Adults with Comorbidities
2021 · Philipe Gobeil, Stéphane Pillet, et al. · medRxiv · 33
USP13 controls the stability of Aurora B impacting progression through the cell cycle
2020 · Mara Esposito, H. Begum Akman, et al. · Oncogene · 33
Impact of tetanus-diphtheria-acellular pertussis immunization during pregnancy on subsequent infant immunization seroresponses: follow-up from a large randomized placebo-controlled trial
2019 · Kirsten P. Perrett, Scott A. Halperin, et al. · Vaccine · 30
Immune interference (blunting) in the context of maternal immunization with Tdap-containing vaccines: is it a class effect?
2020 · Walid Kandeil, Miloje Savic, et al. · Expert Review of Vaccines · 28
Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, parallel, randomised, modified double-blind, placebo-controlled trial
2023 · Gustavo H Dayan, Nadine Rouphael, et al. · The Lancet Respiratory Medicine · 25
PDF
Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines: a phase 3, parallel-group study
2023 · Guy de Bruyn, Joyce Wang, et al. · EClinicalMedicine · 22
PDF
Safety of tetanus, diphtheria, acellular pertussis (Tdap) vaccination during pregnancy
2022 · Hung Fu Tseng, Lina S. Sy, et al. · Vaccine · 20
PDF
Safety of reduced antigen content diphtheria-tetanus-acellular pertussis vaccine when administered during pregnancy as part of the maternal immunization program in Brazil: a single center, observational, retrospective, cohort study
2019 · Mauro Sancovski, Narcisa Mesaros, et al. · Human Vaccines & Immunotherapeutics · 15
PDF
Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 Protein Vaccine
2022 · Gustavo H. Dayan, Nadine Rouphael, et al. · medRxiv · 14
PDF
Impact of maternal diphtheria-tetanus-acellular pertussis vaccination on pertussis booster immune responses in toddlers: Follow-up of a randomized trial
2021 · Federico Martinón-Torres, Scott A. Halperin, et al. · Vaccine · 13
PDF
Durability and cross-reactivity of immune responses induced by a plant-based virus-like particle vaccine for COVID-19
2022 · Philipe Gobeil, Stéphane Pillet, et al. · Nature Communications · 12
PDF
Efficacy of a monovalent (D614) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, multi-country study
2023 · Gustavo H. Dayan, Nadine Rouphael, et al. · EClinicalMedicine · 11
Fourteen years of the Pregnancy Registry on maternal immunisation with a reduced-antigen-content tetanus-diphtheria-acellular pertussis (Tdap) vaccine
2022 · Anastasia Kuznetsova, Maria Angeles Ceregido, et al. · Vaccine · 8
PDF
Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines
2022 · Guy de Bruyn, Joyce Wang, et al. · medRxiv · 7
PDF
Evaluating the Test-Negative Design for COVID-19 Vaccine Effectiveness Using Randomized Trial Data
2025 · Leah I. B. Andrews, M. Elizabeth Halloran, et al. · JAMA Network Open · 6
PDF
Investigating Tetanus, Diphtheria, Acellular Pertussis Vaccination During Pregnancy and Risk of Congenital Anomalies
2022 · Ana Florea, Lina S. Sy, et al. · Infectious Diseases and Therapy · 6
PDF
Durability and Cross-Reactivity of Immune Responses Induced by an AS03-Adjuvanted Plant-Based Recombinant Virus-Like Particle Vaccine for COVID-19
2021 · Philipe Gobeil, Stéphane Pillet, et al. · medRxiv · 3
PDF
Safety and immunogenicity of a homologous booster dose of a SARS-CoV-2 recombinant protein nanoparticle vaccine (GBP510) adjuvanted with AS03: 12 months follow-up result of an open-label, nonrandomized extension of a phase 1/2 trial
2025 · Joon Young Song, Won Suk Choi, et al. · International Journal of Infectious Diseases · 1
Immune interference (blunting) in the context of maternal immunization with Tdap-containing vaccines: is it a class effect?
2020 · Kandeil, Walid, Savic, Miloje, et al. · Figshare
Works count: 25
Citation count: 714
H-index: 14
I10-index: 18
Year
Topic
Type